Wave Life Sciences Ltd.

12/08/2024 | Press release | Distributed by Public on 12/08/2024 19:55

Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy